Author

Lauri Ryyppö

Tampere University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Hanna Selin· 1 shared Jukka‐Pekka MeckliniD· 1 shared Jussi NikkolaiD· 1 shared Juuso Vuorinen· 1 shared Kirsi PylvänäineniD· 1 shared Lauri MoilaneniD· 1 shared Maarit AhtiaineniD· 1 shared Matti AnnalaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Hanna Selin

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell ReportsPeer-reviewedOct 1, 2025

Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer

Jussi Nikkola, Lauri Ryyppö, Juuso Vuorinen…·Matti Annala

This study analyzes the somatic mutation landscape of Lynch syndrome-associated urothelial cancer and finds a lack of TERT promoter mutations and a distinct mutation profile.

2 citations

humanDNA methylation

𝕏 PostBluesky